Compare MasTec Inc (MTZ) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MasTec Inc vs State Street SPDR S&P Biotech ETF — how do they compare? MasTec Inc trades at $350.55 (market cap $26.60B), while State Street SPDR S&P Biotech ETF trades at $154.46. The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, MasTec Inc nearer its low. Which is the better fit depends on your goals.
| MTZ | XBI | |
|---|---|---|
Market Cap | $26.60B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $437.51 | $164.28 |
52-Week Low | $172.51 | $85.16 |
Enterprise Value | $29.34B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About MasTec Inc
MasTec, Inc. is a leading infrastructure construction company operating mainly in North America. The company's services cover a diverse range of end-markets, including communications (building fiber and wireless infrastructure), oil & gas, electric power (transmission, distribution, and clean energy), and industrial projects. MTZ provides critical engineering, procurement, and construction (EPC) services that support the expansion and maintenance of essential infrastructure across the continent.
Read more on MTZ →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
